Kristin DePeaux recently published a paper in the Journal of Experimental Medicine exploring the use of an engineered TGF-beta inhibitor in oncolytic virus immunotherapy for cancer. Check out the article here.
Kristin DePeaux recently published a paper in the Journal of Experimental Medicine exploring the use of an engineered TGF-beta inhibitor in oncolytic virus immunotherapy for cancer. Check out the article here.